13-15 November 2018


Enhancing the Predictive Confidence of Biotherapeutic Design & Developability

Returning 13-15 November, the 3rd Annual CDD for Biologics Summit remains the only industry meeting solely dedicated to exploring the in silico prediction, design, and modelling of biotherapeutics.

Across 3 days of jam-packed content, the event will once again unite computational leaders from pioneering pharmaceutical organizations, academic and software development labs.

As development for the meeting continues, make sure you’re the first to receive updates on the 2018 agenda and speaker faculty as they are released.

Register your interest to attend, present or just learn more here. We’ll be sure to reach out to you with important updates as they occur.

In case you’ve missed CDD for Biologics Summit 2017, download the agenda here.

2017 Highlights Included: 

  1. How Adimab, Just Biotherapeutics and Kadmon have been using machine learning to design, predict developability and prioritise antibody libraries
  2. Alexion & Eli Lilly showcasing their efforts from discovery through to PKPD assessment to optimize the design of monoclonal and bispecific antibodies
  3. EMD Serono & Abbvie discussing organizational barriers and highlighting the strategic implementation and success of CDD in their biologics discovery efforts

“I'm impressed by how much I learned by attending the conference. It's a great opportunity to learn the key issues facing the industry and various strategies to address them.” - Liwei Li, Senior Scientist, EMD Serono

“It's a great conference in the sense that we take home not only new methods and models, but more importantly the design and thinking process behind them.” - Yao Fan, Boehringer Ingelheim

“The conference offered excellent opportunities for networking.” - Eliud Oloo, Sanofi Pasteur

“High praise for gathering such a high-quality group of thought leaders for such a specialized discipline.” - Steven Darnell, DNASTAR, Inc.

2017 Agenda
Download Your Copy


Media Partner